To explore whether increased serum and liver NLRP3 are associated with significant liver pathology, patients with HCV-related liver disease (n = 34) were stratified into two groups according to the severity of liver necroinflammation, fibrosis, and steatosis. Here, NLRP3 is linked to steatosis.